Canadian Pediatricians’ Prescribing Practices for Community-Acquired Pneumonia

Abstract

Get full access to this article

View all access options for this article.

References

McIntosh

. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429-437.

Farha

Thomson

. The burden of pneumonia in children in the developed world. Pediatr Respir Rev. 2005;6:76-82.

Bradley

Byington

Shah

. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-e76.

Le Saux

Robinson

. Pneumonia in healthy Canadian children and youth: practice points for management. Pediatr Child Health. 2011;16:417-420.

Long

Pickering

Prober

, eds. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia, PA: Elsevier; 2008.

Taketomo

Hodding

Kraus

, eds. Pediatric and Neonatal Dosage Handbook. 18th ed. Toronto, Ontario, Canada: Lexi-Comp; 2012.

Harrison

Woods

Stout

Martin

Selvarangan

Susceptibilities of Haemophilus influenza, Streptococcus pneumoniae including serotype 19A, and Moraxella catarrhalis pediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009;63:511-519.

Jacobs

Good

Windau

. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 2010;54:2716-2719.

Jain

Findings from the etiology of pneumonia in the community (EPIC) study. Topic symposium: update on diagnosis and treatment of pediatric community-acquired bacterial pneumonia. Paper presented at: Pediatric Academic Societies Annual Meeting; April 28-May 1, 2012; Boston, MA.

10.

Jenkins

Farrell

. Increase in pneumococcal macrolide resistance, United States. Emerg Infect Dis. 2009;15:1260-1264.

11.

Reinert

RR.

The antimicrobial resistance profile of Streptococcus pneumoniae. Clin Microbiol Infect. 2009;15(suppl 3):7-11.

12.

Karlowsky

Lagacé-Wiens

Low

Zhanel

. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Int J Antimicrob Agents. 2009;34:375-379.